Literature DB >> 28774411

Mechanism and prediction of HCC development in HBV infection.

Weiqi Xu1, Jun Yu2, Vincent Wai-Sun Wong3.   

Abstract

Chronic hepatitis B virus (HBV) infection remains one of the leading causes of hepatocellular carcinoma (HCC) globally. Over the past few decades, the risk factors of HCC in patients with chronic hepatitis B have been well characterized, and can be divided into host and viral factors. A few groups have also derived and validated HCC prediction scores based on these risk factors. In general, the scores have high negative predictive value in identifying a low risk group who may not need HCC surveillance in the next 3-5 years. The scores have been tested originally in Asian patients, and results on their performance in the Caucasian population are conflicting. Furthermore, new research has identified genetic factors and new virological markers (e.g. hepatitis B surface antigen and core-related antigen levels) for HCC, but they are yet to be applied in routine clinical practice.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis B; Entecavir; Hepatocellular carcinoma; Liver cirrhosis; Liver fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28774411     DOI: 10.1016/j.bpg.2017.04.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  6 in total

Review 1.  The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.

Authors:  Naoyoshi Maeda; Katsumi Maenaka
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

2.  Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.

Authors:  Xue-Fang Liu; Khaing Zar Thin; Xin-Liang Ming; Nan-Di Li; Jian-Cheng Tu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

3.  Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis.

Authors:  Jingyuan Zhang; Xinkui Liu; Wei Zhou; Shan Lu; Chao Wu; Zhishan Wu; Runping Liu; Xiaojiaoyang Li; Jiarui Wu; Yingying Liu; Siyu Guo; Shanshan Jia; Xiaomeng Zhang; Miaomiao Wang
Journal:  Front Genet       Date:  2021-09-01       Impact factor: 4.599

Review 4.  Pathogenesis from Inflammation to Cancer in NASH-Derived HCC.

Authors:  Simiao Yu; Jingxiao Wang; Haocheng Zheng; Ruilin Wang; Nadia Johnson; Tao Li; Ping Li; Jie Lin; Yuan Li; Jin Yan; Ying Zhang; Zhenyu Zhu; Xia Ding
Journal:  J Hepatocell Carcinoma       Date:  2022-08-26

5.  The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study.

Authors:  Feng Ye; Wenjuan Zhao; Xueliang Yang; Xi Zhang; Xiaocui An; Ruixue Zhu; Yunru Chen; Xiaojing Liu; Jianzhou Li; Kang Li; Jie Zheng; Shumei Lin; Lei Shi
Journal:  Ann Transl Med       Date:  2022-08

6.  Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells.

Authors:  Fanyun Kong; Yukai Tao; Dongchen Yuan; Ning Zhang; Qi Li; Tong Yu; Xiaoying Yang; Delong Kong; Xiaohui Ding; Xiangye Liu; Hongjuan You; Kuiyang Zheng; Renxian Tang
Journal:  Cancer Res Treat       Date:  2020-11-16       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.